Medical care cost savings from adolescent contraceptive use

Family Planning Perspectives

Volumn 29, Issue 6, 1997, Pages

  Trussell, James ^a,b   Koenig, Jacqueline ^a,b   Stewart, Felicia ^a,c   Darroch, Jacqueline E ^a,d  

^a PRINCETON UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c HENRY J KAISER FAMILY FOUNDATION   (United States)

^d GUTTMACHER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SPERMIDINE;

ADOLESCENT; ADOLESCENT PREGNANCY; ADULT; ARTICLE; CONDOM; CONTRACEPTION; CONTROLLED STUDY; COST CONTROL; DATA BASE; FEMALE; HEALTH CARE COST; HORMONAL CONTRACEPTION; HUMAN; MEDICAID; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT PREGNANCY; ADOLESCENTS; ADOLESCENTS, FEMALE; AGE FACTORS; AMERICAS; CONTRACEPTION; CONTRACEPTIVE USAGE--COST; COST BENEFIT ANALYSIS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; ECONOMIC FACTORS; EVALUATION; FAMILY PLANNING; FERTILITY; INFECTIONS; MACROECONOMIC FACTORS; NORTH AMERICA; NORTHERN AMERICA; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; PRIVATE SECTOR; PUBLIC SECTOR; QUANTITATIVE EVALUATION; REPRODUCTIVE BEHAVIOR; REPRODUCTIVE TRACT INFECTIONS; RESEARCH REPORT; SEXUALLY TRANSMITTED DISEASES; TREATMENT--COST; UNITED STATES; YOUTH;

ADOLESCENT; CALIFORNIA; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; MEDICAID; PREGNANCY; PREGNANCY IN ADOLESCENCE; PRIVATE SECTOR; PUBLIC SECTOR; RISK; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 33749285605     PISSN: 00147354     EISSN: None     Source Type: Journal    
DOI: 10.2307/2953412     Document Type: Article

References (52)

1. J. Trussell, J. J. Card and C. Hogue, "Adolescent Sexual Behavior, Pregnancy, and Childbearing/' in R. A. Hatcher et al., Contraceptive Technology: Seventeenth Revised Edition, Irvington Publishers, New York, 1998, in press; and The Alan Guttmacher Institute (AGI), Sex and America's Teenagers, New York, 1994.
2. AGI, 1994, op. cit. (see reference 1); and S. S. Brown and L. Eisenberg, eds., Tlie Best Intentions: Unintended Pregnancy and the Well-Being of Children and Families, National Academy Press, Washington, DC, 1995.
3. Ibid.
4. AGI, 1994, op. cit. (see reference 1).
5. Centers for Disease Control and Prevention (CDC), Division cfSTD/HlV Prevention 1993 Annual Report, Atlanta, 1994.
6. J. C. Abma et al., "Fertility, Family Planning, and Women's Health: New Data from the 1995 National Survey of Family Growth," Vitaland Health Statistics, Series 23 No. 19,1997
7. J. Trussell, J. J. Card and C. Hogue, 199$ op. cit. (see reference 1); and AGI, 1994, op. cit. (see reference 1).
8. J. C. Abma et al., 1997, op. cit. (see reference 6); and L. Piccinino, personal communication, Mar. 24,1997
9. J. Trussell et al., "The Economic Value of Contraception: A Comparison of 15 Methods," American Journal of Public Health, 85:494-50} 1995; J. D. Koenig et al., "The Social Costs of Inadequate Contraception," Inlernalionat Journal of Technology Assessment in Health Cafe, 12:487-4971996; J. Trussell et al., "Preventing Unintended Pregnancy: The Cost-Effectiveness of Three Methods of Emergency Contraception," American Journal of Public Health, 87:932-937,1997; T. Ashraf, S. B. Arnold and M. Maxfield, "Cost-Effectiveness of Levonorgestrel Subdermal Implants: Comparison with Othef Contraceptive Methods Available in the United States," Journal of Reproductive Medicine, 39:791-7941994; B.C. Ortmeier et al., "A Cost-Benefit Analysis of Four Hormonal Contraceptive Methods," Clinical Tliempeutks, 16:707-713,1994; and J. D. Forrest and R. Samara, "Impact of Publicly Funded Contraceptive Services on Unintended Pregnancies and Implications for Medicaid Expenditures," Family Planning Perspectives, 28:188-195,1996.
10. J. Trussell et al., 1995, op. cit. (see reference 9); and J. Trussell et al., 1997, op. cit. (see reference 9).
11. Ibid.
12. J. Trussell et al., 1995, op. cit. (see reference 9).
13. Ibid.; and J. Trussell and J. Koenig, "Documenting the Economic Value of Contraception: A Comparison of 15 Methods," Methodology Documentation Paper, Office of Population Research, Princeton University, Princeton, NJ, 1995.
14. J. Trussell et al., 1995, op. cit. (see reference 9); and H. B. Peterson, et al., "The Risk of Pregnancy After Tubal Sterilization: Findings from the U.S. Collaborative Review of Sterilization," American Journal of Obstetrics and Gynecology, 174:1161-1170,1996.
15. J. Trussell et al., 1995, op. cit. (see reference 9); and J. Trussell, "Contraceptive Efficacy," in R A. Hatcher et al., 1998, op. cit. (see reference 1).
16. E. F. Jones and J. D. Forrest, "Contraceptive Failure Rates Based on the 1988 NSFG," Family Planning Perspectives, 24:12-19,1992.
17. B. Vaughan, Office of Population Research, Princeton University, unpublished tabulation of data from the 1988 National Survey of Family Growth, Apr. 1996.
18. J. Trussell, J. Strickler and B. Vaughan, "Contraceptive Efficacy of the Diaphragm, the Sponge, and the Cervical Cap," Family Planning Perspectives, 25:100-105 & 135, 1993; and J. Trussell et al., "Comparative Contraceptive Efficacy of the Female Condom and Other Barrier Meth-ods," Family Planning Perspectives, 26:66-72,1994.
19. B. Vaughan, 1996, op. cit. (sec reference 17).
20. S. Harlap, K. Kost and J. D. Forrest, Preventing Pregnancy, Protecting Health: A New Look at Birth Control Cltoices in the United States, AGI, New York, 1991.
21. CDC,DivisionofSTD/HlV Prevention 1992 Annual Report, Atlanta, 1993.
22. Ibid.
23. W. Gates, Jr., CDC, personal communication, Aug. m 1994.
24. J. D. Forrest and S. Singh, "The Sexual and Reproductive Behavior of American Women, 1982-1984" Family Planning Perspectives, 22:206-214,1990.
25. S. Harlap, K. Kost and J. D. Forrest, 1991, op. cit. (see reference 20).
26. J. D. Forrest and S. Singh, 1990, op. cit (see reference 24).
27. S. Harlap, K. Kost and J. D. Forrest, 1991, op. cit. (see reference 20).
28. S. K. Henshaw and J. Silverman, "The Characteristics and Prior Contraceptive Use of U. S. Abortion Patients," Family Planning Perspectives, 20:158-159 & 162-168, 1988.
29. J. D. Forrest and S. Singh, 199Q op. cit (see reference 24).
30. J. Trussell, C. Ellertson and F. Stewart, "The Effectiveness of the Yuzpe Regimen of Emergency Contraception," Family Planning Perspectives, 2858-64 & 87,1996.
31. J. D. Forrest and S. Singh, 1990, op. cit. (see reference 24).
32. S. F. Delbanco, J. Mauldon and M. D. Smith, "Little Knowledge and Limited Practice: Emergency Contraceptive Pills, the Public, and the Obstetrician-Gynecologist," Obstetrics & Gynecology, 89:1006-1011,1997
33. American College of Obstetricians and Gynecologists (ACOG), "Emergency Oral Contraception," ACOG Practice Patterns, No. 3, Washington, DC, 1996.
34. U. S. Food and Drug Administration, "Prescription Drug Products; Certain Combined Oral Contraceptives for Use as Postcoital Emergency Contraception," Federal Register, 62:8610-8612,1997
35. AGI, 1994 op. cit. (see reference 1); and J. C. Abma et al., 1997, op. cit. (see reference 6).
36. A.M. Fraser, J.E. Brockert and R.H. Ward, "Association of Young Maternal Age with Adverse Reproductive Outcomes," New England Journal of Medicine, 332:1113-1117,1995.
37. S. Harlap, K. Kost and J. D. Forrest, 1991, op. cit. (see reference 20).
38. J. Trussell et al., 1995, op. cit. (see reference 9).
39. F.J. Hellinger, "The Lifetime Cost of Treating a Person with HIV," Journal of the American Medical Association, 270:474-47$ 1993.
40. AGI, Uneven & Unequal: Insurance Coverage and Reproductive Health Services, New York, 1994.
41. T. Sollom, R.B. Gold and R. Saul, "Public Funding for Contraceptive, Sterilization and Abortion Sen-ices, 1994," Family Planning Perspectives, 28:166-1751996.
42. AGI, 1994, op. cit. (see reference 40).
43. Ibid.
44. S. Harlap, K. Kost and J. D. Forrcst, 1991, op. cit. (see reference 20).
45. Ibid.
46. Ibid.
47. Ibid.
48. U. S. Bureau of the Census, U.S. Population Estimates, by Age, Sex, Race, and Hispanic Origin: 1990 to 1993, PPL-8, Suitland, MD, Mar. 1994.
49. J. D. Forrcst and S. Singh, 199Q op. cit (see reference 24).
50. CDC, 1991 op. cit. (see reference 21).
51. W. Cates, Jr., op. cit. (see reference 23).
52. W. Cates, Jr., "Vaginal Spermicides," in R. A. Hatcher et al., 1998, op. cit. (see reference 1); and F. Stewart, "Vaginal Barriers: The Diaphragm, Contraceptive Sponge, Cervical Cap, and Female Condom," ibid.